Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 2/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL5139174 | 0.79 | SRC (0.46) | ATML3MBTL1CYP2D6SRCLMNA | |
| SCHEMBL8671904 | 0.79 | ATM (0.44) | ATML3MBTL1CYP2D6SRCLMNA | |
| SCHEMBL12458246 | 0.79 | ATM (0.44) | ATML3MBTL1CYP2D6SRCLMNA | |
| SCHEMBL28044484 | 0.78 | CYP2D6 (0.44) | ATML3MBTL1CYP2D6SRCLMNA | |
| SCHEMBL7955519 | 0.78 | SRC (0.50) | ATML3MBTL1CYP2D6SRCLMNA | |
| SCHEMBL4026079 | 0.78 | SRC (0.50) | ATML3MBTL1CYP2D6SRCLMNA | |
| SCHEMBL195532 | 0.78 | SRC (0.50) | ATML3MBTL1CYP2D6SRCLMNA | |
| SCHEMBL29773675 | 0.76 | SRC (0.48) | ATML3MBTL1CYP2D6SRCLMNA | |
| SCHEMBL6971672 | 0.76 | CYP2D6 (0.43) | ATML3MBTL1CYP2D6SRCLMNA | |
| Hydrochloric Acid SCHEMBL2529822 | 0.76 | SRC (0.48) | ATML3MBTL1CYP2D6SRCLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7741513-B2 | Thioacids and thioacid salts for determining the enantiomeric excess of chiral compounds containing an electrophilic carbon center | RICHMAN JACK E | 2010-06-22 | — | — | US | disclosed |
| US-20090181462-A1 | Thioacids and thioacid salts for determining the enantiomeric excess of chiral compounds containing an electrophilic carbon center | RICHMAN JACK E | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181462-A1 | Thioacids and thioacid salts for determining the enantiomeric excess of chiral compounds containing an electrophilic carbon center | TST, SLC6A6, MPST | ATM 4311/4885L3MBTL1 1857/4885CYP2D6 498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.